GSK Seeks Marketing Partner (India)
This article was originally published in PharmAsia News
As part of its attempt to enhance its therapeutic coverage in cardiovascular, diabetes and other high-growth segments, the Indian division of GlaxoSmithKline is searching for brand in-licensing opportunities to market products for lifestyle-related diseases. GlaxoSmithKline Pharmaceuticals Managing Director Hasit B. Joshipura has confirmed that the company is hunting "for partners and we are in discussions with a couple of companies." The announcement marks a departure for GSK's portfolio, which has consisted mainly of traditional therapeutic segments. The redirection will include rolling out products from GSK's portfolio, Joshipura added. (Click here for more
You may also be interested in...
In an open letter to the European Commission, Parliament and Council presidents, more than 400 cosmetics companies and animal-rights groups accuse the European Chemicals Agency of effectively “shredding” the animal testing ban on cosmetics by requiring testing for certain chemicals under REACH.
Pink Sheet reporters and editors look at the UK MHRA’s surprising approval of the Pfizer/BioNTech coronavirus vaccine, as well as the US reaction, and discuss President-elect Joe Biden’s potential US FDA commissioner nominees.
Divesting the heart valve division will allow LivaNova to focus more resources on its neuromodulation, cardiopulmonary and circulatory support businesses.